Evidence map›Paper›PMID 34888064›Full record

ArticleJournal of clinical and translational science2021

The Recruitment Innovation Center: Developing novel, person-centered strategies for clinical trial recruitment and retention.

Consuelo H Wilkins, Terri L Edwards, Mary Stroud, Nan Kennedy, Rebecca N Jerome, Colleen E Lawrence, Sheila V Kusnoor, Sarah Nelson, Loretta M Byrne, Leslie R Boone and 8 more

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Optimizing participation in digital health studies: understanding appointment attendance.Journal of the American Medical Informatics Association : JAMIA · 2026
    Article
  6. Article
  7. Article
  8. Use of advance letters to enhance participant retention in a clinical trial.Journal of clinical and translational science · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Amyloid PET and clinical management in a diverse, cognitively impaired population: The New IDEAS Study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Observational
  13. Article
  14. Article
  15. Article
  16. Insights from the trial innovation network's initial consultation process.Journal of clinical and translational science · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Consuelo H WilkinsVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.
Terri L EdwardsVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.
Mary StroudVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.
Nan KennedyVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.
Rebecca N JeromeVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.ORCID https://orcid.org/0000-0002-6023-4269
Colleen E LawrenceVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.
Sheila V KusnoorCenter for Knowledge Management, Strategy and Innovation, Vanderbilt University Medical Center, Nashville, TN 37203 USA.
Sarah NelsonVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.
Loretta M ByrneVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.ORCID https://orcid.org/0000-0003-0009-1144
Leslie R BooneVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.
Julia DunaganVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.
Tiffany IsraelVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.ORCID https://orcid.org/0000-0002-0852-8390
Casey RodwellerVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.
Bethany DruryVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.
Rhonda G KostCenter for Clinical and Translational Science, The Rockefeller University, New York, NY, USA.ORCID https://orcid.org/0000-0002-5419-0589
Jill M PulleyVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.
Gordon R BernardVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.
Paul A HarrisVanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.ORCID https://orcid.org/0000-0002-1744-2011

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
Improving Clinical trial Education, Recruitment, and Enrollment at CTSA Hubs (I-CERCH) - HEAL SupplementU24TR001579 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRIS, PAUL A., WILKINS, CONSUELO HOPKINS · 2016 to 2022
$34.1M
NCATS NIH HHS U24 TR001579NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR001866NCATS NIH HHS UL1 TR002243
6 · The paper itself

Abstract

Clinical trials continue to face significant challenges in participant recruitment and retention. The Recruitment Innovation Center (RIC), part of the Trial Innovation Network (TIN), has been funded by the National Center for Advancing Translational Sciences of the National Institutes of Health to develop innovative strategies and technologies to enhance participant engagement in all stages of multicenter clinical trials. In collaboration with investigator teams and liaisons at Clinical and Translational Science Award institutions, the RIC is charged with the mission to design, field-test, and refine novel resources in the context of individual clinical trials. These innovations are disseminated via newsletters, publications, a virtual toolbox on the TIN website, and RIC-hosted collaboration webinars. The RIC has designed, implemented, and promised customized recruitment support for 173 studies across many diverse disease areas. This support has incorporated site feasibility assessments, community input sessions, recruitment materials recommendations, social media campaigns, and an array of study-specific suggestions. The RIC's goal is to evaluate the efficacy of these resources and provide access to all investigating teams, so that more trials can be completed on time, within budget, with diverse participation, and with enough accrual to power statistical analyses and make substantive contributions to the advancement of healthcare.

Indexed as

CTSA programmulticenter clinical trialsparticipant recruitmentparticipant retentionTranslational research

Identifiers

PMID34888064
PMCPMC8634298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.